Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HORA-PDE6B / Coave Therap
NCT03328130 / 2016-001429-16: Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene	Recruiting	1/2	23	Europe	AAV2/5-hPDE6B	eyeDNA Therapeutics	Retinitis Pigmentosa	12/29	12/29
HORA-RLBP1 / Coave Therap
No trials found
CTx-GBA1 / Coave Therap
No trials found
CTx-FUS / Coave Therap
No trials found
TFEB AAV-based gene therapy / Coave Therap
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HORA-PDE6B / Coave Therap
NCT03328130 / 2016-001429-16: Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene	Recruiting	1/2	23	Europe	AAV2/5-hPDE6B	eyeDNA Therapeutics	Retinitis Pigmentosa	12/29	12/29
HORA-RLBP1 / Coave Therap
No trials found
CTx-GBA1 / Coave Therap
No trials found
CTx-FUS / Coave Therap
No trials found
TFEB AAV-based gene therapy / Coave Therap
No trials found